Yen Chung

Evaluating direct costs and productivity losses of patients with asthma receiving GINA 4/5 therapy in the United States

Russell A. Settipane, James L. Kreindler, Yen Chung et al. · Annals of Allergy Asthma & Immunology · 2019 · 81 citations · Full text

<p>Patient and physician preferences for attributes of biologic medications for severe asthma</p>

Heather L. Gelhorn, Zaneta Balantac, Christopher S. Ambrose et al. · Patient Preference and Adherence · 2019 · 57 citations · Full text

Oral Corticosteroid Treatment Patterns of Patients in the United States with Persistent Asthma

Trung N. Tran, Sharon MacLachlan, Wesley L. Hicks et al. · The Journal of Allergy and Clinical Immunology In Practice · 2020 · 42 citations

Clinical and economic burden of severe asthma among US patients treated with biologic therapies

Joan Reibman, Laren Tan, Chris Ambrose et al. · Annals of Allergy Asthma & Immunology · 2021 · 42 citations · Full text

Systemic Corticosteroid-Related Complications and Costs in Adults with Persistent Asthma

Robert S. Zeiger, Patrick W. Sullivan, Yen Chung et al. · The Journal of Allergy and Clinical Immunology In Practice · 2020 · 36 citations

Asthma, Allergy, Allergic Rhinitis +3